Who needs secondary prevention?
- PMID: 28618916
- DOI: 10.1177/2047487317706112
Who needs secondary prevention?
Abstract
Secondary prevention for ischaemic heart disease can be defined as a comprehensive set of measures, aiming to reduce the recurrence of cardiovascular disease and to improve long-term prognosis. Despite its proven efficacy, uptake and adherence rates remain poor. This paper summarises the available European recommendations for secondary prevention in varying ischaemic heart disease populations, including those patients with specific co-morbidities. The scientific evidence supporting these recommendations is provided. The article relates to the European Association of Preventive Cardiology, the Acute Cardiovascular Care Association and the Council on Cardiovascular Nursing and Allied Professions Secondary Prevention After Acute Myocardial Infarction framework in that it clarifies accurately who needs secondary prevention.
Keywords: Secondary prevention; chronic kidney disease; elderly; heart failure; ischaemic heart disease.
Similar articles
-
Secondary prevention: Where we are.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):14-21. doi: 10.1177/2047487317704978. Eur J Prev Cardiol. 2017. PMID: 28618902 Review.
-
Planning secondary prevention: Room for improvement.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):22-28. doi: 10.1177/2047487317704954. Eur J Prev Cardiol. 2017. PMID: 28618903 Review.
-
Improving adherence to medication for secondary cardiovascular disease prevention.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):29-35. doi: 10.1177/2047487317708145. Eur J Prev Cardiol. 2017. PMID: 28618909 Review.
-
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.Eur J Prev Cardiol. 2017 Jun;24(3_suppl):61-70. doi: 10.1177/2047487317707854. Eur J Prev Cardiol. 2017. PMID: 28618904 Review.
-
Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.Eur J Prev Cardiol. 2015 Oct;22(10):1354-62. doi: 10.1177/2047487314546825. Epub 2014 Aug 19. Eur J Prev Cardiol. 2015. PMID: 25139770
Cited by
-
Wearable Monitoring and Interpretable Machine Learning Can Objectively Track Progression in Patients during Cardiac Rehabilitation.Sensors (Basel). 2020 Jun 26;20(12):3601. doi: 10.3390/s20123601. Sensors (Basel). 2020. PMID: 32604829 Free PMC article.
-
Use of health services and perceived need for information and follow-up after percutaneous coronary intervention.BMC Res Notes. 2024 Jan 5;17(1):20. doi: 10.1186/s13104-023-06662-y. BMC Res Notes. 2024. PMID: 38183067 Free PMC article.
-
Participation in a comprehensive cardiac rehabilitation program improves mid- and long-term prognosis in survivors of acute coronary syndrome.Am J Prev Cardiol. 2025 Jun 13;23:101042. doi: 10.1016/j.ajpc.2025.101042. eCollection 2025 Sep. Am J Prev Cardiol. 2025. PMID: 40606515 Free PMC article.
-
Using machine learning to predict acute myocardial infarction and ischemic heart disease in primary care cardiovascular patients.PLoS One. 2024 Jul 18;19(7):e0307099. doi: 10.1371/journal.pone.0307099. eCollection 2024. PLoS One. 2024. PMID: 39024245 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources